Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Investigating the Relationship Between Rare Genetic Variants and Fibrosis in Pediatric Nonalcoholic Fatty Liver Disease.

Julia Wattacheril | Sarah E Kleinstein | Patrick R Shea | Laura A Wilson | G Mani Subramanian | Robert P Myers | Jay Lefkowitch | Cynthia Behling | Stavra A Xanthakos | David B Goldstein | NASH Clinical Research Network
medRxiv : the preprint server for health sciences | 2024

Nonalcoholic Fatty Liver Disease (NAFLD) is a complex human disease. Common genetic variation in the patatin-like phospholipase domain containing 3 (PNPLA3) and transmembrane 6 superfamily member 2 (TM6SF2) genes have been associated with an increased risk of developing NAFLD, nonalcoholic steatohepatitis (NASH), and fibrosis in adults. The role of rare genetic variants in the development and progression of NAFLD in children is not well known. We aimed to explore the role of rare genetic variants in pediatric patients with advanced fibrosis.

Pubmed ID: 38496563

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: NIDDK NIH HHS, United States
    Id: U01 DK061718
  • Agency: NCATS NIH HHS, United States
    Id: UL1 TR000006
  • Agency: NIDDK NIH HHS, United States
    Id: U01 DK061728
  • Agency: NCATS NIH HHS, United States
    Id: UL1 TR000454
  • Agency: NIDDK NIH HHS, United States
    Id: U01 DK061734
  • Agency: NCATS NIH HHS, United States
    Id: UL1 TR000004
  • Agency: NIDDK NIH HHS, United States
    Id: U01 DK061737
  • Agency: NIDDK NIH HHS, United States
    Id: U01 DK061713
  • Agency: NIDDK NIH HHS, United States
    Id: U01 DK061732
  • Agency: NCATS NIH HHS, United States
    Id: UL1 TR000150
  • Agency: NIDDK NIH HHS, United States
    Id: U01 DK061730
  • Agency: NIDDK NIH HHS, United States
    Id: U24 DK061730
  • Agency: NIDDK NIH HHS, United States
    Id: U01 DK061738
  • Agency: NCATS NIH HHS, United States
    Id: UL1 TR000424
  • Agency: NCATS NIH HHS, United States
    Id: UL1 TR002378
  • Agency: NCATS NIH HHS, United States
    Id: UL1 TR000448
  • Agency: NCATS NIH HHS, United States
    Id: UL1 TR000040
  • Agency: NCATS NIH HHS, United States
    Id: UL1 TR000077
  • Agency: NCATS NIH HHS, United States
    Id: UL1 TR000423
  • Agency: NCATS NIH HHS, United States
    Id: UL1 TR000100

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


GATK (tool)

RRID:SCR_001876

A software package to analyze next-generation resequencing data. The toolkit offers a wide variety of tools, with a primary focus on variant discovery and genotyping as well as strong emphasis on data quality assurance. Its robust architecture, powerful processing engine and high-performance computing features make it capable of taking on projects of any size. This software library makes writing efficient analysis tools using next-generation sequencing data very easy, and second it's a suite of tools for working with human medical resequencing projects such as 1000 Genomes and The Cancer Genome Atlas. These tools include things like a depth of coverage analyzers, a quality score recalibrator, a SNP/indel caller and a local realigner. (entry from Genetic Analysis Software)

View all literature mentions

ClinicalTrials.gov (tool)

RRID:SCR_002309

Registry and results database of federally and privately supported clinical trials conducted in United States and around world. Provides information about purpose of trial, who may participate, locations, and phone numbers for more details. This information should be used in conjunction with advice from health care professionals.Offers information for locating federally and privately supported clinical trials for wide range of diseases and conditions. Research study in human volunteers to answer specific health questions. Interventional trials determine whether experimental treatments or new ways of using known therapies are safe and effective under controlled environments. Observational trials address health issues in large groups of people or populations in natural settings. ClinicalTrials.gov contains trials sponsored by National Institutes of Health, other federal agencies, and private industry. Studies listed in database are conducted in all 50 States and in 178 countries.

View all literature mentions

SnpEff (tool)

RRID:SCR_005191

Genetic variant annotation and effect prediction software toolbox that annotates and predicts effects of variants on genes (such as amino acid changes). By using standards, such as VCF, SnpEff makes it easy to integrate with other programs.

View all literature mentions

Picard (tool)

RRID:SCR_006525

Java toolset for working with next generation sequencing data in the BAM format.

View all literature mentions